MRL Advisors – Selected News China – First Half 2025
The policy and business landscape in China is constantly evolving, creating new opportunities and avenues. However, navigating the complexities of these news and separating the signal from the noise can be challenging, with risks of following the wrong trends or missing relevant updates. At MRL Advisors, our dedicated teams on the ground in China stay […]
Joint venture China, subsidiary (WFOE) or hybrid?
By Frank-Christan Raffel Frank-Christian Raffel has been analyzing and shaping the strategy and corporate form of European companies in China and Southeast Asia since 1997, when he conducted a broad-based study in cooperation with the Hong Kong and Shanghai Chambers of Commerce. It is remarkable how often we hear the question even today, in the […]
IDS – White Paper Dental Market CHINA: Opportunities with new strategic approaches in a challenging environment
By Frank-Christian Raffel The Chinese dental market continues to be the fastest growing and strategically most important market in the world, with particular challenges for international companies. Ahead of IDS in Cologne in February 2025, MRL Advisors published a white paper incl. results of the survey of dental product suppliers from Germany, Austria and Switzerland […]
MRL Advisors – Selected News China – Second Half 2024
The policy and business landscape in China is constantly evolving, creating new opportunities and avenues. However, navigating the complexities of these news and separating the signal from the noise can be challenging, with risks of following the wrong trends or missing relevant updates. At MRL Advisors, our dedicated teams on the ground in China stay […]
AI-powered medical imaging in the Chinese healthcare market: revolutionizing radiology
By Frank-Christian Raffel The healthcare sector in China is in the midst of a profound transformation, driven by the use of artificial intelligence (AI) in medical imaging. Through massive investment and rapid technological advancement, AI is transforming radiology while providing new opportunities to improve diagnostic accuracy, optimize workflows and expand access to healthcare services. Fig. […]
Selling companies to China and the USA – Still possible from a regulatory perspective?
By MRL Advisors Research Germany, as the EU’s largest economy, has revised and tightened its screening mechanisms for foreign direct investment (FDI) in recent years. Investments in key sectors such as AI, semiconductors, quantum computing and biotechnology were scrutinized with increased attention, particularly in response to global trends towards technological sovereignty. Does this mean the […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]
Project “Service Excellence” – NETZSCH grows with service in China
By Frank-Christian Raffel Together with the managers of NETZSCH Pumpen & Systeme, Waldkraiburg and Lanzhou, MRL Advisors has shaped the strategic direction of NETZSCH’s service business, particularly in China, in a global project. Starting Point NETZSCH Pumpen & Systeme is the global market leader for progressive cavity pumps. The management of NETZSCH, represented by Mr. […]